Elanco
Tiffany Kanaga is an accomplished finance professional with extensive experience in investor relations and equity research. Currently serving as Vice President of Investor Relations & ESG at Elanco since January 2025, Tiffany has previously held leadership positions including Vice President of Global Investor Relations at Walgreens Boots Alliance and Head of Investor Relations at Elanco. Tiffany's background in equity research includes a tenure as Director at Deutsche Bank, where notable achievements include recognition as a II Rising Star in Retailing in 2017 and 2018. Tiffany's earlier roles include positions at The Buckingham Research Group, Citi, Anheuser-Busch InBev, and J.P. Morgan. Tiffany holds an MBA in Marketing and Management from Columbia Business School and dual bachelor's degrees in Management Science and French from the Massachusetts Institute of Technology.
This person is not in any teams
This person is not in any offices
Elanco
28 followers
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.